Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1813796

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1813796

U.S. Laparotomy Sponge Market Size, Share & Trends Analysis Report By Product, By End-use, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 125 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 3950
Printable PDF & Excel (5-User License)
USD 4950
Printable PDF & Excel (Enterprise License)
USD 6950

Add to Cart

U.S. Laparotomy Sponge Market Trends:

The U.S. laparotomy sponge market size was valued at USD 422.7 million in 2024 and is projected to reach USD 706.9 million by 2033, growing at a CAGR of 5.9% from 2025 to 2033. Key factors driving growth include a rise in abdominal surgeries due to conditions such as cancer and hernias, as well as an increase in C-sections. Demand is further enhanced by concerns regarding retained surgical items, which have led to the adoption of radiopaque and RFID-enabled sponges. Additionally, the growth is fueled by the aging population, increased surgical volumes in outpatient settings, and advancements in sponge design and materials, all supported by regulatory emphasis on surgical safety and infection control.

Additionally, the U.S. is witnessing heightened focus on surgical safety, particularly in preventing retained surgical items (RSIs). RSIs, especially sponges, are among the most common and dangerous surgical errors, leading to severe complications, repeat surgeries, infections, and even fatalities. For instance, according to the National Quality Forum (NQF), 2,000-4,000 cases of retained surgical items (RSIs) are reported yearly in the U.S., where sponges are the most frequently retained objects.

Laparotomy sponges are used in sterile, high-bleeding-risk operations, including resections. According to the American Cancer Society, approximately 106,180 new colorectal cases were recorded in the U.S., many of which require open (laparotomy) procedures, where sponges are essential for fluid management and tissue retraction.

Sustainability, ergonomic design, and targeted customization are emerging as influential factors in the evolution of laparotomy sponges in the U.S. healthcare market. As hospitals increasingly prioritize environmentally responsible procurement, manufacturers are responding by developing laparotomy sponges made with eco-friendly materials, reduced packaging waste, and biodegradable components. These innovations align with broader institutional goals of lowering medical waste and achieving greener operating room practices. In a market that has historically focused on functionality and cost, sustainability is now becoming a competitive differentiator, especially among large hospital systems aiming to meet ESG (Environmental, Social, and Governance) targets.

In parallel, ergonomic design and procedure-specific customization are enhancing surgical efficiency and safety. Modern laparotomy sponges are being developed with features such as reinforced edges for easier retrieval, improved texture for better fluid absorption, and color-coded systems to assist in intraoperative tracking. Some products are even customized based on surgical specialty-such as gynecologic oncology or trauma care, ensuring optimal size, shape, and absorbency for the intended use.

U.S. Laparotomy Sponge Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. laparotomy sponge market report based on product and end-use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Radiopaque Laparotomy Sponge
  • Traditional Laparotomy Sponge
  • Radio-frequency Identification (RFID) Laparotomy Sponge
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Others
Product Code: GVR-4-68040-705-0

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End-use
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. U.S. Laparotomy Sponge Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising number of laparotomy surgeries
      • 3.2.1.2. Growing prevalence of abdominal disorders
      • 3.2.1.3. Growing geriatric population
      • 3.2.1.4. Advancements in surgical safety regulations
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of laparotomy sponges
  • 3.3. Laparotomy Sponge Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. U.S. Laparotomy Sponge Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Laparotomy Sponge Market: Product Movement Analysis
  • 4.3. Laparotomy Sponge Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Radiopaque Laparotomy Sponge
    • 4.5.1. Radiopaque Laparotomy Sponge Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Traditional Laparotomy Sponge
    • 4.6.1. Traditional Laparotomy Sponge Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Radio-frequency Identification (RFID) Laparotomy Sponge
    • 4.7.1. Radio-frequency Identification (RFID) Laparotomy Sponge Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Laparotomy Sponge Market: End-use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Laparotomy Sponge Market: End-use Movement Analysis
  • 5.3. Laparotomy Sponge Market by End-use Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Hospitals & Clinics
    • 5.5.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Key Company Profiles
    • 6.2.1. Integra LifeSciences
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Medical Action Industries Inc.
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. SDP Inc.
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Dukal, LLC
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Stryker
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Cardinal Health
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. AllCare
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. DeRoyal Industries Inc.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Allmed Medical Products Co.,Ltd.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Premier Enterprises
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
Product Code: GVR-4-68040-705-0

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. laparotomy sponge market, by product, 2021 - 2033 (USD Million)
  • Table 4 U.S. laparotomy sponge market, by end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. laparotomy sponge: market outlook
  • Fig. 9 U.S. laparotomy sponge market competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 U.S. laparotomy sponge market driver impact
  • Fig. 15 U.S. laparotomy sponge market restraint impact
  • Fig. 16 U.S. laparotomy sponge market strategic initiatives analysis
  • Fig. 17 U.S. laparotomy sponge market: product movement analysis
  • Fig. 18 U.S. laparotomy sponge market: product outlook and key takeaways
  • Fig. 19 Radiopaque laparotomy sponge market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Traditional laparotomy sponge market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Radio-frequency Identification (RFID) laparotomy sponge market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Laparotomy sponge market, end use outlook key takeaways (USD Million)
  • Fig. 23 Laparotomy sponge market end use movement analysis 2024 & 2033 (USD Million)
  • Fig. 24 Hospitals & clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Participant categorization- U.S. laparotomy sponge market
  • Fig. 27 Market share of key market players- U.S. laparotomy sponge market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!